147 related articles for article (PubMed ID: 15190008)
1. Production of a complement inhibitor possessing sialyl Lewis X moieties by in vitro glycosylation technology.
Thomas LJ; Panneerselvam K; Beattie DT; Picard MD; Xu B; Rittershaus CW; Marsh HC; Hammond RA; Qian J; Stevenson T; Zopf D; Bayer RJ
Glycobiology; 2004 Oct; 14(10):883-93. PubMed ID: 15190008
[TBL] [Abstract][Full Text] [Related]
2. Characterization of N-linked oligosaccharides bearing sialyl lewis x moieties on an alternatively glycosylated form of soluble complement receptor type 1 (sCR1).
Picard MD; Pettey CL; Marsh HC; Thomas LJ
Biotechnol Appl Biochem; 2000 Feb; 31(1):5-13. PubMed ID: 10669397
[TBL] [Abstract][Full Text] [Related]
3. alpha(1,2)-fucosylation prevents sialyl Lewis x expression and E-selectin-mediated adhesion of fucosyltransferase VII-transfected cells.
Zerfaoui M; Fukuda M; Sbarra V; Lombardo D; El-Battari A
Eur J Biochem; 2000 Jan; 267(1):53-61. PubMed ID: 10601850
[TBL] [Abstract][Full Text] [Related]
4. Recombinant glycoproteins that inhibit complement activation and also bind the selectin adhesion molecules.
Rittershaus CW; Thomas LJ; Miller DP; Picard MD; Geoghegan-Barek KM; Scesney SM; Henry LD; Sen AC; Bertino AM; Hannig G; Adari H; Mealey RA; Gosselin ML; Couto M; Hayman EG; Levin JL; Reinhold VN; Marsh HC
J Biol Chem; 1999 Apr; 274(16):11237-44. PubMed ID: 10196211
[TBL] [Abstract][Full Text] [Related]
5. The monoclonal antibody CHO-131 binds to a core 2 O-glycan terminated with sialyl-Lewis x, which is a functional glycan ligand for P-selectin.
Walcheck B; Leppanen A; Cummings RD; Knibbs RN; Stoolman LM; Alexander SR; Mattila PE; McEver RP
Blood; 2002 Jun; 99(11):4063-9. PubMed ID: 12010808
[TBL] [Abstract][Full Text] [Related]
6. Moderation of skeletal muscle reperfusion injury by a sLe(x)-glycosylated complement inhibitory protein.
Kyriakides C; Wang Y; Austen WG; Favuzza J; Kobzik L; Moore FD; Hechtman HB
Am J Physiol Cell Physiol; 2001 Jul; 281(1):C224-30. PubMed ID: 11401845
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of alpha-2,3-sialyltransferases and alpha-1,3/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells.
Carvalho AS; Harduin-Lepers A; Magalhães A; Machado E; Mendes N; Costa LT; Matthiesen R; Almeida R; Costa J; Reis CA
Int J Biochem Cell Biol; 2010 Jan; 42(1):80-9. PubMed ID: 19781661
[TBL] [Abstract][Full Text] [Related]
8. α2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues.
Pérez-Garay M; Arteta B; Llop E; Cobler L; Pagès L; Ortiz R; Ferri MJ; de Bolós C; Figueras J; de Llorens R; Vidal-Vanaclocha F; Peracaula R
Int J Biochem Cell Biol; 2013 Aug; 45(8):1748-57. PubMed ID: 23726834
[TBL] [Abstract][Full Text] [Related]
9. Glycosyl-transferase catalyzed assemblage of sialyl-Lewis(x)-saccharopeptides.
Baisch G; Ohrlein R
Bioorg Med Chem; 1998 Oct; 6(10):1673-82. PubMed ID: 9838999
[TBL] [Abstract][Full Text] [Related]
10. Sialyl-Lewis(x) on P-selectin glycoprotein ligand-1 is regulated during differentiation and maturation of dendritic cells: a mechanism involving the glycosyltransferases C2GnT1 and ST3Gal I.
Julien S; Grimshaw MJ; Sutton-Smith M; Coleman J; Morris HR; Dell A; Taylor-Papadimitriou J; Burchell JM
J Immunol; 2007 Nov; 179(9):5701-10. PubMed ID: 17947642
[TBL] [Abstract][Full Text] [Related]
11. Reduction of myocardial infarct size with sCR1sLe(x), an alternatively glycosylated form of human soluble complement receptor type 1 (sCR1), possessing sialyl Lewis x.
Zacharowski K; Otto M; Hafner G; Marsh HC; Thiemermann C
Br J Pharmacol; 1999 Nov; 128(5):945-52. PubMed ID: 10556930
[TBL] [Abstract][Full Text] [Related]
12. 5-Aza-2'-deoxycytidine increases sialyl Lewis X on MUC1 by stimulating β-galactoside:α2,3-sialyltransferase 6 gene.
Chachadi VB; Cheng H; Klinkebiel D; Christman JK; Cheng PW
Int J Biochem Cell Biol; 2011 Apr; 43(4):586-93. PubMed ID: 21168523
[TBL] [Abstract][Full Text] [Related]
13. Endothelial targeting and enhanced antiinflammatory effects of complement inhibitors possessing sialyl Lewisx moieties.
Mulligan MS; Warner RL; Rittershaus CW; Thomas LJ; Ryan US; Foreman KE; Crouch LD; Till GO; Ward PA
J Immunol; 1999 Apr; 162(8):4952-9. PubMed ID: 10202042
[TBL] [Abstract][Full Text] [Related]
14. Effect of ST3GAL 4 and FUT 7 on sialyl Lewis X synthesis and multidrug resistance in human acute myeloid leukemia.
Ma H; Zhou H; Li P; Song X; Miao X; Li Y; Jia L
Biochim Biophys Acta; 2014 Sep; 1842(9):1681-92. PubMed ID: 24953795
[TBL] [Abstract][Full Text] [Related]
15. Competition between core-2 GlcNAc-transferase and ST6GalNAc-transferase regulates the synthesis of the leukocyte selectin ligand on human P-selectin glycoprotein ligand-1.
Lo CY; Antonopoulos A; Gupta R; Qu J; Dell A; Haslam SM; Neelamegham S
J Biol Chem; 2013 May; 288(20):13974-13987. PubMed ID: 23548905
[TBL] [Abstract][Full Text] [Related]
16. Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers.
Julien S; Ivetic A; Grigoriadis A; QiZe D; Burford B; Sproviero D; Picco G; Gillett C; Papp SL; Schaffer L; Tutt A; Taylor-Papadimitriou J; Pinder SE; Burchell JM
Cancer Res; 2011 Dec; 71(24):7683-93. PubMed ID: 22025563
[TBL] [Abstract][Full Text] [Related]
17. Core saccharide dependence of sialyl Lewis X biosynthesis.
Löfling J; Holgersson J
Glycoconj J; 2009 Jan; 26(1):33-40. PubMed ID: 18607721
[TBL] [Abstract][Full Text] [Related]
18. Carcinoembryonic antigen carrying SLe
Gomes C; Almeida A; Barreira A; Calheiros J; Pinto F; Abrantes R; Costa A; Polonia A; Campos D; Osório H; Sousa H; Pinto-de-Sousa J; Kolarich D; Reis CA
Theranostics; 2019; 9(24):7431-7446. PubMed ID: 31695778
[TBL] [Abstract][Full Text] [Related]
19. Expression and function of alpha 2,3-sialyl- and alpha 1,3/1,4-fucosyltransferases in colon adenocarcinoma cell lines: role in synthesis of E-selectin counter-receptors.
Majuri ML; Niemelä R; Tiisala S; Renkonen O; Renkonen R
Int J Cancer; 1995 Nov; 63(4):551-9. PubMed ID: 7591266
[TBL] [Abstract][Full Text] [Related]
20. Engineering of coordinated up- and down-regulation of two glycosyltransferases of the O-glycosylation pathway in Chinese hamster ovary (CHO) cells.
Prati EG; Matasci M; Suter TB; Dinter A; Sburlati AR; Bailey JE
Biotechnol Bioeng; 2000 May; 68(3):239-44. PubMed ID: 10745191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
